Coronary Artery Disease. We see you. September 2026 Quarterly Report - Timing & Investor Webinar Investor Call 11am AEDT (8am AWST), Monday 26 October 2026 PERTH, Australia, 22 October 2026: Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology ® company commercialising its Salix...
Artrya September Quarter - Report Timing & Investor Webinar
Filed with ASX · · 1 page · English
Release
Earlier from Artrya
- Notice of Annual General Meeting/Proxy Form
- Application for quotation of securities - AYA
- Issue of Shares on Exercise of Securities & Cleansing Notice
- Huntsville Hospital Health System Commercial Agreement
- Ceasing to be a substantial holder
Later from Artrya
All Artrya news releasesFollow Artrya into a list and get an email when it puts out news.
Follow Artrya